Alendronate

Trade Name: 
Fosamax
Manufacturer/Distributor: 
Merck
Classification: 
Bone resorption inhibitor
ATC Class: 
M05BA04 Alendronic Acid
Status: 
discontinued
Date Marketed in Canada (yyyy/mm/dd): 
2011/03
Presentation: 
Tablet: 10 mg. DIN: 02201011
Oral solution: 75 mg/75 mL. DIN: 02248625
Comments: 
The 10 mg tablet strength is discontinued as of March 2011. There are generic manufacturers. The 75 mg/75 mL oral solution is discontinued as of March 2011. There do not appear to be other manufacturers of the oral solution in Canada.